The monitoring does not need to be burdensome, but it should be consistent
Glucagon-like peptide-1 receptor (GLP-1) agonist medications have become increasingly popular thanks to their effectiveness for weight loss and blood sugar management
But the pharmacokinetic profile and clinical response differ significantly across body weight ranges
In addition to avoiding potential issues like constipation, dry skin, or lightheadedness, adequate water intake is important because its associated with satiety and fullness as well
Individuals taking these medications should supplement with products that help meet these needs and focus on making foundational lifestyle changes to achieve sustainable weight loss. Analyzing GLP-1 Nutritional Support Market by Top Investment Segments The GLP-1 nutritional support market is segmented by product type into protein & macronutrient blends, fiber supplements, micronutrient blends, and digestive health formulations
However, the risk of cholelithiasis, micronutrient deficiencies and lean muscle mass loss during the rapid WL phase are of particular concern with the new obesity treatments
